Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website. 

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Karmanos, WSU Faculty Members Selected by Michigan Cancer Consortium to Support Statewide Cancer Control Efforts

The Michigan Cancer Consortium (MCC) has selected two Barbara Ann Karmanos Cancer Institute researchers and Wayne State University School of Medic...

Read More

Abstracts Now Accepted for 3rd Annual Science of Community Outreach and Engagement Conference, Co-Hosted by Karmanos, WSU

Abstracts are now being accepted for the Science of Community Outreach and Engagement Conference (SoCOE), which will be held May 6-8 at the Cambri...

Read More

Karmanos Cancer Institute Receives the 2026 Women’s Choice Award® as One of America’s Best Hospitals for Cancer Care

Karmanos Cancer Hospital, part of the Barbara Ann Karmanos Cancer Institute , has been named one of America’s Best Hospitals for Cancer Care in 20...

Read More
News

WSGW | Risks of Pancreatic Cancer

Listen Now

WWJ | Karmanos Psychologist on Emotional Impact of Breast Cancer Diagnosis

Listen Now

WWJ | ‘Houses with Roofs Caved In’: Karmanos Surgeon Explains Stage 0 Breast Cancer (DCIS)

Listen Now
View All Podcasts